Introduction: The difficulty of understanding and diagnosing drug-induced liver injury (DILI)
has led to proliferation of serum and genetic biomarkers. Many applications of these …

Amiodarone is a benzofuran class III antiarrhythmic drug used to treat a wide spectrum of
ventricular tachyarrhythmias. The parenteral formulation is prepared in polysorbate 80 …

Besides synthetic drugs, a wide variety of medicinal plants have been used for the
prevention and management of various liver disorders. Generally, plant therapies are well …

Background Intravenous (IV) amiodarone may be associated with liver injury that may
necessitate drug discontinuation. The prediction of amiodarone induced liver injury (AILI) …

Amiodarone is a highly effective treatment for life-threatening supraventricular and
ventricular arrhythmias, namely in the setting of acutely decompensated heart failure …

Amiodaron jest lekiem antyarytmicznym powszechnie stosowanym w terapii zaburzeń rytmu
serca. Ze względu na bardzo długi okres półtrwania, lipofilną budowę i gromadzenie w …

The deterioration of hepatorenal function due to worsening congestion is relatively common
in acute heart failure and carries an independent adverse prognosis. In some patients, the …

Background: Amiodarone is a commonly used drug with a long half-life that is associated
with asymptomatic hepatotoxicity; however, acute toxicity is rare, with few reported cases of …

ANTECEDENTES: La amiodarona es un fármaco de administración común, de vida media
larga que se asocia con hepatotoxicidad asintomática; sin embargo, la toxicidad aguda es …

As a class III antiarrhythmic, amiodarone has been widely used in the management of
arrhythmia despite its extensive side effect profile. There have been reports of hepatotoxicity …